The Development of ELISA-test System for Detection of Specific IgG to SARS-COV-2 Coronavirus by Immunoblotting (Line Blot)

Relevance. The problem of timely and effective diagnosis of COVID-19 remains one of the main problems facing healthcare. In this regard, the task of developing test systems for the etiological diagnosis of COVID-19 remains extremely relevant. Purpose To develop ELISA test system for detection of G s...

Full description

Saved in:
Bibliographic Details
Main Authors: S. G. Mardanly, T. V. Popova
Format: Article
Language:Russian
Published: Numikom LLC 2022-09-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
Online Access:https://www.epidemvac.ru/jour/article/view/1617
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250225529552896
author S. G. Mardanly
T. V. Popova
author_facet S. G. Mardanly
T. V. Popova
author_sort S. G. Mardanly
collection DOAJ
description Relevance. The problem of timely and effective diagnosis of COVID-19 remains one of the main problems facing healthcare. In this regard, the task of developing test systems for the etiological diagnosis of COVID-19 remains extremely relevant. Purpose To develop ELISA test system for detection of G specific immunoglobulins to SARS-COV-2 coronavirus by immunoblotting (Line Blot). Methods. Elaboration of techniques for obtaining test components and preliminary assessment of its diagnostic effectivenessin blood serums from COVID-19 patients treated at N. I. Pirogov First Gradsky Hospital, Moscow, and serums from healthy human donors. Results. The study of 104 blood serum samples from COVID-19 patients and 100 blood serum samples from healthy human donors, pre-tested by ELISA IgG to SARS-CoV-2 using «Vitrotest SARS-CoV-2 IgG» test systems (Vitrotest, Ukraine) and «ELISA-SARS-CoV-2-AB-G» (CJSC EKOlab, Russia) showed high diagnostic efficiency of the new test system. Conclusion. The new test system after state registration of the medical device can be recommended as a confirmatory test for the etiological laboratory diagnosis of COVID-19.
format Article
id doaj-art-ac3e6b65f7b3451d9bf406e5d506cc55
institution Kabale University
issn 2073-3046
2619-0494
language Russian
publishDate 2022-09-01
publisher Numikom LLC
record_format Article
series Эпидемиология и вакцинопрофилактика
spelling doaj-art-ac3e6b65f7b3451d9bf406e5d506cc552025-08-20T03:57:18ZrusNumikom LLCЭпидемиология и вакцинопрофилактика2073-30462619-04942022-09-0121410311210.31631/2073-3046-2022-21-4-103-112863The Development of ELISA-test System for Detection of Specific IgG to SARS-COV-2 Coronavirus by Immunoblotting (Line Blot)S. G. Mardanly0T. V. Popova1State University of Humanities and Technology; Closed Joint Stock Company EKOlab (CJSC EKOlab)Closed Joint Stock Company EKOlab (CJSC EKOlab)Relevance. The problem of timely and effective diagnosis of COVID-19 remains one of the main problems facing healthcare. In this regard, the task of developing test systems for the etiological diagnosis of COVID-19 remains extremely relevant. Purpose To develop ELISA test system for detection of G specific immunoglobulins to SARS-COV-2 coronavirus by immunoblotting (Line Blot). Methods. Elaboration of techniques for obtaining test components and preliminary assessment of its diagnostic effectivenessin blood serums from COVID-19 patients treated at N. I. Pirogov First Gradsky Hospital, Moscow, and serums from healthy human donors. Results. The study of 104 blood serum samples from COVID-19 patients and 100 blood serum samples from healthy human donors, pre-tested by ELISA IgG to SARS-CoV-2 using «Vitrotest SARS-CoV-2 IgG» test systems (Vitrotest, Ukraine) and «ELISA-SARS-CoV-2-AB-G» (CJSC EKOlab, Russia) showed high diagnostic efficiency of the new test system. Conclusion. The new test system after state registration of the medical device can be recommended as a confirmatory test for the etiological laboratory diagnosis of COVID-19.https://www.epidemvac.ru/jour/article/view/1617covid-19sars-cov-2laboratory diagnosticsdevelopmenttest systemline-blot
spellingShingle S. G. Mardanly
T. V. Popova
The Development of ELISA-test System for Detection of Specific IgG to SARS-COV-2 Coronavirus by Immunoblotting (Line Blot)
Эпидемиология и вакцинопрофилактика
covid-19
sars-cov-2
laboratory diagnostics
development
test system
line-blot
title The Development of ELISA-test System for Detection of Specific IgG to SARS-COV-2 Coronavirus by Immunoblotting (Line Blot)
title_full The Development of ELISA-test System for Detection of Specific IgG to SARS-COV-2 Coronavirus by Immunoblotting (Line Blot)
title_fullStr The Development of ELISA-test System for Detection of Specific IgG to SARS-COV-2 Coronavirus by Immunoblotting (Line Blot)
title_full_unstemmed The Development of ELISA-test System for Detection of Specific IgG to SARS-COV-2 Coronavirus by Immunoblotting (Line Blot)
title_short The Development of ELISA-test System for Detection of Specific IgG to SARS-COV-2 Coronavirus by Immunoblotting (Line Blot)
title_sort development of elisa test system for detection of specific igg to sars cov 2 coronavirus by immunoblotting line blot
topic covid-19
sars-cov-2
laboratory diagnostics
development
test system
line-blot
url https://www.epidemvac.ru/jour/article/view/1617
work_keys_str_mv AT sgmardanly thedevelopmentofelisatestsystemfordetectionofspecificiggtosarscov2coronavirusbyimmunoblottinglineblot
AT tvpopova thedevelopmentofelisatestsystemfordetectionofspecificiggtosarscov2coronavirusbyimmunoblottinglineblot
AT sgmardanly developmentofelisatestsystemfordetectionofspecificiggtosarscov2coronavirusbyimmunoblottinglineblot
AT tvpopova developmentofelisatestsystemfordetectionofspecificiggtosarscov2coronavirusbyimmunoblottinglineblot